Arrowhead Research

Arrowhead Research

Arrowhead Research

Arrowhead Research Corporation is a biopharmaceutical company developing targeted RNAi therapeutics
Founded
2004
Raised
$114.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$9,600,000
Post-IPO equity - 2017
Silence Therapeutics
$45,000,000
Post-IPO equity - 2016
OrbiMed
Team Size
1–10
Employees
$9,600,000 Private equity
Xconomy

Arrowhead Nets $9.6M Investment From U.K.-Based Silence Therapeutics

The Motley Fool

Better Buy: Inovio Pharmaceuticals or Arrowhead Research Corp.?

The Motley Fool

Why Keurig Green Mountain, Arrowhead Research, and Smith & Wesson Jumped on Monday --

Stock markets